Relief Therapeutics Holding SA
(OTC: RLFTY)
|
1:35 PM UTC, 07/02/24 | |||
---|---|---|---|---|
Last: $1.29 | Change: -0.07 | %Change: -4.78% | Volume: 650 |
Open: | $ 1.29 | Volume: | 650 | |
---|---|---|---|---|
High: | $ 1.29 | Yield(%) | 0.00 | |
Low: | $ 1.29 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 72,691.25 | |
EPS ($) | n/a | Shares Out: | 55,069.13 |
% Price Change (last 4 weeks): | 0.68 |
---|---|
% Price Change (last 13 weeks): | -4.06 |
% Price Change (last 26 weeks): | -43.58 |
% Price Change (last 52 weeks): | -56.88 |
% Price Change (year to date): | -44.16 |
Return on Equity (%): | -99.67 |
---|---|
Return on Assets (%): | -74.11 |
Return on Invested Capital (%): | -42.78 |
Gross Profit Margin (%): | -179.99 |
---|---|
Net Profit Margin (%): | -1627.40 |
Operating Profit Margin (%): | -329.92 |
|
|
50-day Moving Average: | $1.05 |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | 246 |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $3.82 |
52-wk low: | $1.29 |
Bid: | $n/a |
Ask: | $n/a |
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
|
Relief Therapeutics Holding SA
Avenue de Sécheron 15 Geneva GE 1202 Phone: 41.22.545.11.16 Fax: n/a http://www.relieftherapeutics.com |
Earnings (1year) ($): | -9.34 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 4.95 |
Cash Flow ($): | -8.42 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 4.14 |
Price/Book (x): | 0.48 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 2.57 |
---|---|
Current Ratio (x): | 2.65 |
LT Debt/Equity (x): | 4.01 |
Total Debt/Equity (x): | 8.25 |